Phase I trial investigating the effect of valproic acid on the pharmacokinetics of lersivirine

Trial Profile

Phase I trial investigating the effect of valproic acid on the pharmacokinetics of lersivirine

Completed
Phase of Trial: Phase I

Latest Information Update: 05 Jan 2012

At a glance

  • Drugs Lersivirine (Primary) ; Valproic acid
  • Indications Epilepsy; HIV infections
  • Focus Pharmacokinetics
  • Most Recent Events

    • 05 Jan 2012 New trial record
    • 01 Nov 2011 Results published in the British Journal of Clinical Pharmacology.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top